The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118242634 11824263 4 F 20160705 20151210 20160713 EXP BR-JNJFOC-20151204461 JANSSEN 0.00 A M Y 88.00000 KG 20160713 MD BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118242634 11824263 1 PS TOPAMAX TOPIRAMATE 1 Oral U U 20505 UNSPECIFIED
118242634 11824263 2 C LOSARTAN. LOSARTAN 1 Unknown 0 UNSPECIFIED
118242634 11824263 3 C ATENOLOL. ATENOLOL 1 Unknown 0 UNSPECIFIED
118242634 11824263 4 C FUROSEMIDE. FUROSEMIDE 1 Unknown 0 UNSPECIFIED
118242634 11824263 5 C ATORVASTATIN ATORVASTATIN 1 Unknown 0 UNSPECIFIED
118242634 11824263 6 C MESALAZINE MESALAMINE 1 Unknown 0 TABLETS
118242634 11824263 7 C AZATHIOPRINE. AZATHIOPRINE 1 Unknown 0 UNSPECIFIED
118242634 11824263 8 C METFORMIN METFORMIN HYDROCHLORIDE 1 Unknown 0 UNSPECIFIED
118242634 11824263 9 C RIVOTRIL CLONAZEPAM 1 Unknown 0 UNSPECIFIED
118242634 11824263 10 C REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) 0 LYOPHILIZED POWDER
118242634 11824263 11 C REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) 0 LYOPHILIZED POWDER
118242634 11824263 12 C METHOTREXATE. METHOTREXATE 1 Unknown 0 TABLETS
118242634 11824263 13 C OMEPRAZOLE. OMEPRAZOLE 1 Unknown 0 UNSPECIFIED
118242634 11824263 14 C AMITRIPTYLINE AMITRIPTYLINE 1 U 0
118242634 11824263 15 C PHENOBARBITAL. PHENOBARBITAL 1 Unknown U 0
118242634 11824263 16 C CIPROFIBRATE CIPROFIBRATE 1 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118242634 11824263 1 Epilepsy
118242634 11824263 2 Hypertension
118242634 11824263 3 Hypertension
118242634 11824263 4 Hypertension
118242634 11824263 5 Blood cholesterol
118242634 11824263 6 Product used for unknown indication
118242634 11824263 7 Product used for unknown indication
118242634 11824263 8 Product used for unknown indication
118242634 11824263 9 Product used for unknown indication
118242634 11824263 10 Crohn's disease
118242634 11824263 11 Crohn's disease
118242634 11824263 12 Product used for unknown indication
118242634 11824263 13 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
118242634 11824263 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
118242634 11824263 Cerebral atrophy
118242634 11824263 Crohn's disease
118242634 11824263 Diabetes mellitus
118242634 11824263 Osteoporosis
118242634 11824263 Rheumatic disorder
118242634 11824263 Seizure
118242634 11824263 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
118242634 11824263 10 20150515 0
118242634 11824263 11 20151222 0